News Conference News CRT 2025 AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years L.A. McKeown March 10, 2025
News Conference News CRT 2023 In CABG/PCI Decisions for Left Main Disease, Diabetes ‘Still Matters’ Yael L. Maxwell March 01, 2023
News Conference News CRT 2021 BIOSTEMI at 2 Years: Orsiro Continues to Lower TLF in STEMI Patients Caitlin E. Cox March 16, 2021
News Conference News CRT 2020 Meta-analysis Upholds Complete PCI in STEMI, as Thoughts Turn to Timing, Costs Michael O'Riordan February 24, 2020
News Conference News CRT 2019 ORBITA Absorbed: Principal Investigator Reflects on How Results Have Changed Her Practice Yael L. Maxwell March 07, 2019